Jonathan Alspaugh
Insider
First SEC filing: Feb. 22, 2022 · Latest: Feb. 22, 2022
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 22, 2023 | SYRE | A | 19,787,969 | · | · | 19,787,969 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2023 | SYRE | A | 640,000 | · | · | 640,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 23, 2022 | SYRE | A | 130,000 | · | · | 130,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 11, 2022 | SYRE | P | 75,000 | $2.08 | $156,000 | 165,372 Direct | +82.99% | Acquired | 79.2% (price as of 2026-10-02) |
| Feb. 17, 2022 | SYRE | A | 170,000 | · | · | 170,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 9, 2021 | SYRE | P | 50,000 | $3.72 | $186,000 | 90,372 Direct | +123.85% | Acquired | 0.2% (price as of 2026-10-02) |
| Aug. 18, 2021 | SYRE | P | 7,200 | $6.72 | $48,384 | 40,372 Direct | +21.71% | Acquired | -44.5% (price as of 2026-10-02) |
| Aug. 17, 2021 | SYRE | P | 23,392 | $6.50 | $152,048 | 33,172 Direct | +239.18% | Acquired | -42.7% (price as of 2026-10-02) |
| Aug. 16, 2021 | SYRE | P | 9,780 | $6.37 | $62,299 | 9,780 Direct | · | Acquired | -41.5% (price as of 2026-10-02) |
| July 6, 2021 | SYRE | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2023 | SYRE | Employee Stock Option (right to buy) | Common Stock | $0.30 | June 22, 2033 | 19,787,969 | Acquired |
| Feb. 23, 2023 | SYRE | Employee Stock Option (right to buy) | Common Stock | $0.44 | Feb. 22, 2033 | 640,000 | Acquired |
| Aug. 23, 2022 | SYRE | Employee Stock Option (right to buy) | Common Stock | $0.68 | Aug. 22, 2032 | 130,000 | Acquired |
| Feb. 17, 2022 | SYRE | Employee Stock Option (right to buy) | Common Stock | $3.17 | Feb. 16, 2032 | 170,000 | Acquired |
| July 6, 2021 | SYRE | Employee Stock Option (right to buy) | Common Stock | $7.03 | July 5, 2031 | 160,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $329,767 | $735,647 | · | · | · | · | $234,692 | $8,360,029 |
| 2022 | $425,001 | · | · | · | $130,560 | · | $12,994 | $1,011,840 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.